Abstract | BACKGROUND/AIMS: METHODS: A genotype analysis of CX3CR1 variants was performed in 211 HCV-infected patients. Hepatic expression of CX3CR1 was studied in HCV-infected livers and isolated liver cell populations by RT-PCR and immunohistochemistry. The effects of fractalkine on mRNA expression of profibrogenic genes were determined in isolated hepatic stellate cells (HSC) and CX3CR1 genotypes were related to intrahepatic TIMP-1 mRNA levels. RESULTS: The intrahepatic mRNA expression of CX3CR1 correlates with the stage of HCV-induced liver fibrosis (P=0.03). The CX3CR1 coding variant V249I is associated with advanced liver fibrosis, independent of the T280M variant (P=0.009). CX3CR1 is present on primary HSC and fractalkine leads to a suppression of tissue inhibitor of metalloproteinase (TIMP)-1 mRNA in HSC (P=0.03). Furthermore, CX3CR1 genotypes are associated with TIMP-1 mRNA expression in HCV-infected liver (P=0.03). CONCLUSIONS:
|
Authors | Hermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, Alexa Werth, David Scholten, Sonja Hillebrandt, Frank Tacke, Petra Schmitz, Edgar Dahl, Tonio Wiederholt, Claus Hellerbrand, Thomas Berg, Ralf Weiskirchen, Christian Trautwein, Frank Lammert |
Journal | Journal of hepatology
(J Hepatol)
Vol. 48
Issue 2
Pg. 208-15
(Feb 2008)
ISSN: 0168-8278 [Print] Netherlands |
PMID | 18078680
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CX3C Chemokine Receptor 1
- CX3CR1 protein, human
- RNA, Messenger
- Receptors, Chemokine
- Tissue Inhibitor of Metalloproteinase-1
|
Topics |
- CX3C Chemokine Receptor 1
- Genotype
- Hepatitis C, Chronic
(complications, genetics)
- Humans
- Liver
(metabolism)
- Liver Cirrhosis
(etiology, genetics)
- Polymorphism, Single Nucleotide
- RNA, Messenger
(analysis)
- Receptors, Chemokine
(genetics)
- Tissue Inhibitor of Metalloproteinase-1
(genetics)
|